M/04/006 – Abbott Laboratories/TheraSense
Transaction details
Proposal whereby Abbott Laboratories (“Abbott”) would acquire all the issued shares of TheraSense, Inc.
| Notification date | Decision date |
|---|---|
| Monday January 26, 2004 | Thursday, February 26, 2004 |
| Parties Involved | Business activities |
|---|---|
| Abbott Laboratories | |
| TheraSense | TheraSense develops, manufactures and sells glucose monitoring systems designed to reduce the pain of testing for people with diabetes. |
| Economic sector | Media merger |
|---|---|
| Health Care | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Current status: Completed |
|---|
| Preliminary investigation (Phase 1) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| . | . |
Media enquiries: MKC Communications: 01 7038600
Haven’t found what you’re looking for?
Scroll
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555